Impact of Delayed Early Antiretroviral Therapy Initiation on Treatment Outcomes in Infant Macaques Exposed to SHIVAD8
Viruses · 2025
DOI: 10.3390/v17060849 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Li Ma und 11 weiteren Autor:innen. Beteiligte Einrichtung: Tulane National Primate Research Center, Tulane University School of Medicine, 18703 Three Rivers Road, Covington, LA 70433, USA. Hauptthemen laut MEDLINE: Simian Acquired Immunodeficiency Syndrome, Simian Immunodeficiency Virus, Anti-Retroviral Agents, HIV Infections. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ODCDC CDC HHS, NIH HHS, NIMH NIH HHS.
Abstract (Originalsprache)
Infants born to HIV-positive mothers remain at significant risk of HIV acquisition despite maternal adherence to antiretroviral therapy, cesarean delivery, and formula feeding. Our previous study reported that initiating early antiretroviral treatment at three days post-SIV infection resulted in approximately eighty percent of pediatric virologic remission. In this study, we investigated treatment outcomes in postnatally SHIV-exposed infant macaques when early intervention was delayed by two days, as well as the mechanisms underlying virologic control. The results showed that, although initiating treatment at five days post-exposure effectively suppressed viral replication, only one of the three infant macaques achieved a sustained state of virologic remission following analytical treatment interruption. Notably, this virus-controlled infant lacked detectable virus-specific immunity, including neutralizing antibodies, cytotoxic T cell responses, and antibody-dependent cellular cytotoxicity. These findings highlight the critical importance of early treatment initiation as a key determinant of virologic control in HIV-exposed, infected infants. This study provides valuable insights for guiding early pediatric HIV intervention strategies in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tulane National Primate Research Center, Tulane University School of Medicine, 18703 Three Rivers Road, Covington, LA 70433, USA.
- Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
- Department of Medicine, Infectious Diseases, Boston University School of Medicine, Boston Medical Center, 650 Albany Street, Boston, MA 02118, USA.
ORCID-Profile: Li Ma, Xueling Wu, Olivia Donau, Robert V Blair, Malcolm Martin, Ronald S Veazey, Huanbin Xu, Xiaolei Wang
Förderung
- ODCDC CDC HHS
- NIH HHS
- NIMH NIH HHS
- NICHD NIH HHS
- national Institute of Child Health and Human Development
- National Institutes of Health
- Division of Intramural Research Program of NIAID/NIH
Zitieren
APA
Ma, L., Nishimura, Y., Wu, X., Donau, O., Vincent, E., Lu, H., Blair, R. V., Doyle-Meyers, L. A., Martin, M., Veazey, R. S., Xu, H., & Wang, X. (2025). Impact of Delayed Early Antiretroviral Therapy Initiation on Treatment Outcomes in Infant Macaques Exposed to SHIVAD8. Viruses. https://doi.org/10.3390/v17060849
Vancouver
Ma L, Nishimura Y, Wu X, Donau O, Vincent E, Lu H, et al. Impact of Delayed Early Antiretroviral Therapy Initiation on Treatment Outcomes in Infant Macaques Exposed to SHIVAD8. Viruses. 2025. doi:10.3390/v17060849
BibTeX
@article{Ma2025,
author = {Ma, Li and Nishimura, Yoshiaki and Wu, Xueling and Donau, Olivia and Vincent, Eunice and Lu, Hong and Blair, Robert V and Doyle-Meyers, Lara A and Martin, Malcolm and Veazey, Ronald S and Xu, Huanbin and Wang, Xiaolei},
title = {Impact of Delayed Early Antiretroviral Therapy Initiation on Treatment Outcomes in Infant Macaques Exposed to SHIVAD8},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17060849}
}
EUVIMED